Utah has reported 27 cases so far; Arizona has 42 confirmed cases, including 1 child who has been hospitalized.

HealthDay News — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published in the Journal of ...

HealthDay News — During August 2021 to August 2023, only 36.4% of US adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National Center for ...

HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...

Researchers explored the impact of polypharmacy on long-term treatment response among patients with early rheumatoid arthritis.

Psychosocial symptoms improved with encounters with a behavioral health clinician and psychotropic prescription.

North Carolina and Idaho are cutting their Medicaid programs to bridge budget gaps, raising fears that providers will stop taking patients.

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, called Trump’s comments dangerous. Fevers can harm the mother and the developing fetus, she said, ...

HealthDay News — Louisiana health officials have confirmed a fifth death this year linked to Vibrio vulnificus, a rare and dangerous flesh-eating bacteria found in warm coastal waters.

Maxillary sinusitis is characterized by facial pain and pressure in the cheek area that worsens with bending over or lying ...

HealthDay News — A deep learning model based on mammographic features and age predicts cardiovascular risk with performance comparable to traditional risk equations, according to a study published ...